01st December 2021 | Pharma Updates
Why Learning and Development matters for pharma
The robust L&D department helps employees adapt to a fast-changing work environment.
Fresh opportunities for India in global Active Pharmaceutical Ingredients market
V K Singh, COO – Chemical SBU, Cadila Pharma, traces the development of the Active Pharmaceutical Ingredients industry in India and the journey ahead.
Why is BioPharma Breaking Research and Development shackles
India’s pharma market has observed partnerships and collaborations between major pharma/biopharma companies for the development of newer drugs for the treatment of patients with chronic diseases and Covid.
Vifor Pharma declares changes to the EC as CFO retires
The drug company is currently in the hiring process for the new CFO.
Moderna denies sharing Covid vaccine recipe to Africa
In the US and Europe, monopolies on the crucial development to make vaccines largely remains controlled by private drug companies that received a huge amount of money from governments to make vaccines.
India ready to supply medical supplies to Africa
India has made a promise to supply PPE kits, ventilators, life-saving drugs, gloves, testing kits and much more.
Sai Life Sciences' API manufacturing site gets Certificate of Inspection from PMDA, Japan
Japan’s regulatory agency, Pharmaceuticals and Medical Devices Agency has completed compliance inspection of its intermediate & API manufacturing unit in Bidar, India
